tiprankstipranks
Advertisement
Advertisement

VYNE Stock Latest News

VYNE declares special dividend ahead of Yarrow merger
Company AnnouncementsVYNE declares special dividend ahead of Yarrow merger
10h ago
8K
VYNE
VYNE Therapeutics declares special cash dividend with Yarrow Bioscience merger
PremiumThe Fly
VYNE Therapeutics declares special cash dividend with Yarrow Bioscience merger
10h ago
VYNE
VYNE Highlights Yarrow Merger Strategy and Endocrine Pipeline
PremiumCompany Announcements
VYNE Highlights Yarrow Merger Strategy and Endocrine Pipeline
2M ago
8K
VYNE
VYNE Therapeutics Granted Nasdaq Extension to Regain Compliance
PremiumCompany Announcements
VYNE Therapeutics Granted Nasdaq Extension to Regain Compliance
4M ago
8K
VYNE
VYNE Therapeutics Amends Merger Terms with Yarrow Bioscience
PremiumCompany Announcements
VYNE Therapeutics Amends Merger Terms with Yarrow Bioscience
5M ago
8K
VYNE
3 Penny Stocks to Watch Now, 12/18/25
PremiumMarket News3 Penny Stocks to Watch Now, 12/18/25
7M ago
BEAT
VYNE
Hold Rating for VYNE Therapeutics Amid Strategic Shift and Clinical Uncertainty Following Yarrow Bioscience Merger
Premium
Ratings
Hold Rating for VYNE Therapeutics Amid Strategic Shift and Clinical Uncertainty Following Yarrow Bioscience Merger
7M ago
VYNE
VYNE Therapeutics Announces Merger with Yarrow Bioscience
Premium
Company Announcements
VYNE Therapeutics Announces Merger with Yarrow Bioscience
7M ago
8K
VYNE
VYNE Therapeutics, Yarrow Bioscience enter merger agreement
PremiumThe Fly
VYNE Therapeutics, Yarrow Bioscience enter merger agreement
7M ago
VYNE
VYNE Therapeutics Approves Director Elections and Proposals
PremiumCompany Announcements
VYNE Therapeutics Approves Director Elections and Proposals
7M ago
8K
VYNE
VYNE Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
VYNE Therapeutics Reports Q3 2025 Financial Results
8M ago
VYNE
VYNE Therapeutics reports Q3 EPS (17c) vs (29c) last year
PremiumThe Fly
VYNE Therapeutics reports Q3 EPS (17c) vs (29c) last year
8M ago
VYNE
VYNE Therapeutics Faces Nasdaq Non-Compliance Notice
PremiumCompany AnnouncementsVYNE Therapeutics Faces Nasdaq Non-Compliance Notice
10M ago
8K
VYNE
VYNE Therapeutics Reports Q2 2025 Financials and Updates
Premium
Company Announcements
VYNE Therapeutics Reports Q2 2025 Financials and Updates
11M ago
VYNE
VYNE Therapeutics: Hold Rating Amid Mixed Clinical Outcomes and Financial Sustainability
Premium
Ratings
VYNE Therapeutics: Hold Rating Amid Mixed Clinical Outcomes and Financial Sustainability
11M ago
VYNE
VYNE Therapeutics Directors Resign Amid Financial Updates
PremiumCompany Announcements
VYNE Therapeutics Directors Resign Amid Financial Updates
11M ago
8K
VYNE
VYNE Therapeutics reports Q2 EPS (13c) vs (22c) last year
PremiumThe Fly
VYNE Therapeutics reports Q2 EPS (13c) vs (22c) last year
11M ago
VYNE
VYNE Earnings this Week: How Will it Perform?
PremiumPre-Earnings
VYNE Earnings this Week: How Will it Perform?
11M ago
VYNE
Watch Out! Analysts Have Recently Downgraded These Stocks
PremiumMarket News
Watch Out! Analysts Have Recently Downgraded These Stocks
11M ago
AMD
NEO
Why Is VYNE Therapeutics Stock (VYNE) Down 70% Today?
PremiumMarket NewsWhy Is VYNE Therapeutics Stock (VYNE) Down 70% Today?
11M ago
VYNE
VYNE Therapeutics downgraded to Neutral from Buy at BTIG
Premium
The Fly
VYNE Therapeutics downgraded to Neutral from Buy at BTIG
11M ago
VYNE
VYNE Therapeutics: Buy Rating Supported by Promising VYN202 Prospects Amidst Challenges
Premium
Ratings
VYNE Therapeutics: Buy Rating Supported by Promising VYN202 Prospects Amidst Challenges
12M ago
VYNE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >